Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001415889-24-016256

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2024-06-10 Grant or award · Stock Option (Right to Buy) +25,000 25,000 I
Loading xslF345X05/form4-06102024_090635.xml…